Farther Finance Advisors LLC Has $63,000 Position in CorVel Co. (NASDAQ:CRVL)

Farther Finance Advisors LLC trimmed its position in CorVel Co. (NASDAQ:CRVL) by 59.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 564 shares of the business services provider’s stock after selling 844 shares during the quarter. Farther Finance Advisors LLC’s holdings in CorVel were worth $63,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Boston Trust Walden Corp increased its position in shares of CorVel by 196.8% in the fourth quarter. Boston Trust Walden Corp now owns 690,053 shares of the business services provider’s stock worth $76,775,000 after purchasing an additional 457,538 shares during the period. State Street Corp grew its stake in CorVel by 0.8% during the third quarter. State Street Corp now owns 360,068 shares of the business services provider’s stock worth $117,703,000 after buying an additional 2,959 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in CorVel by 203.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 261,644 shares of the business services provider’s stock valued at $29,111,000 after buying an additional 175,408 shares during the period. Geode Capital Management LLC raised its position in shares of CorVel by 3.9% in the 3rd quarter. Geode Capital Management LLC now owns 253,870 shares of the business services provider’s stock valued at $83,000,000 after buying an additional 9,571 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of CorVel during the 4th quarter worth approximately $25,123,000. Institutional investors and hedge funds own 51.36% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com lowered CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

Insider Activity at CorVel

In other CorVel news, Director Jeffrey J. Michael sold 10,477 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $116.45, for a total value of $1,220,046.65. Following the completion of the sale, the director now owns 568,310 shares in the company, valued at approximately $66,179,699.50. This trade represents a 1.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Steven J. Hamerslag sold 10,000 shares of the company’s stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the transaction, the director now owns 314,000 shares of the company’s stock, valued at $38,772,720. This trade represents a 3.09 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,200 shares of company stock worth $3,824,115 in the last quarter. Company insiders own 47.57% of the company’s stock.

CorVel Price Performance

NASDAQ:CRVL opened at $107.86 on Friday. CorVel Co. has a one year low of $76.20 and a one year high of $128.61. The firm’s 50 day simple moving average is $112.06 and its 200 day simple moving average is $114.20. The company has a market cap of $5.54 billion, a PE ratio of 63.45 and a beta of 1.06.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.